AbbVie Inc. vs Johnson & Johnson: Stock Comparison
Share price, earnings, valuation and dividends side by side.
AbbVie Inc. has a market cap of $515B and Johnson & Johnson $665B, so Johnson & Johnson is about 1.3 times the size of AbbVie Inc..
Revenue growth (YoY) is +10.4% for AbbVie Inc. and +7.8% for Johnson & Johnson.
Operating margin is 29.3% for AbbVie Inc. and 25.7% for Johnson & Johnson.
The P/E ratio (TTM) is 82.1x for AbbVie Inc. and 41.8x for Johnson & Johnson.
Dividend yield is 2.38% for AbbVie Inc. and 1.91% for Johnson & Johnson.
In each row, the better figure is highlighted based only on the number itself. This does not say which is the better investment.
| ABBVAbbVie Inc.Healthcare | JNJJohnson & JohnsonHealthcare | |
|---|---|---|
| Basics | ||
| Market cap | $515B | $665B |
| Share price | $291.31 | $276.22 |
| 1-year return | +37.0% | +51.1% |
| 5-year return | +196.9% | +94.3% |
| Valuation | ||
| P/E (TTM) | 82.1x | 41.8x |
| Forward P/E | 20.9x | 24.7x |
| P/S | 8.0x | 6.7x |
| P/B | -86.9x | 7.9x |
| EV/EBITDA | 27.3x | 22.5x |
| Profitability | ||
| Revenue (TTM) | $64.4B | $99.3B |
| Gross margin | 71.5% | 68.8% |
| Operating margin | 29.3% | 25.7% |
| Net margin | 9.8% | 16.2% |
| ROE | −136.5% | 19.7% |
| Growth | ||
| Revenue growth (YoY) | +10.4% | +7.8% |
| Revenue CAGR (5Y) | +6.0% | +2.7% |
| EPS CAGR (5Y) | −2.7% | +14.9% |
| Dividends & balance sheet | ||
| Dividend yield | 2.38% | 1.91% |
| Years of dividend growth | — | — |
| FCF yield | 3.5% | 2.8% |
| Debt/equity (lower = less debt) | -11.93x | 0.58x |
Other comparisons
Listed mechanically from public data. Not a recommendation to buy or sell any security.